Reaves AB - Search Results

1

Risk of venous thromboembolism in hospitalized patients with peripherally inserted central catheters.

Lobo BL, Vaidean G, Broyles J, Reaves AB, Shorr RI. Lobo BL, et al. Among authors: reaves ab. J Hosp Med. 2009 Sep;4(7):417-22. doi: 10.1002/jhm.442. J Hosp Med. 2009. PMID: 19753569

2

Underutilization of Aldosterone Antagonists in Heart Failure.

Patterson SJ, Reaves AB, Tolley EA, Ulrich D, Hilty C, Clarke CJ, Self TH. Patterson SJ, et al. Among authors: reaves ab. Hosp Pharm. 2017 Nov;52(10):698-703. doi: 10.1177/0018578717724886. Epub 2017 Aug 20. Hosp Pharm. 2017. PMID: 29276242 Free PMC article.

3

Analysis of antithrombotic therapy after cardioembolic stroke due to atrial fibrillation or flutter.

Peterson EJ, Reaves AB, Smith JL, Oliphant CS. Peterson EJ, et al. Among authors: reaves ab. Hosp Pharm. 2013 Feb;48(2):127-33. doi: 10.1310/hpj4802-127.test. Hosp Pharm. 2013. PMID: 24421450 Free PMC article.

4

Enzalutamide-warfarin interaction necessitating warfarin dosage adjustment: A case report of successful clinical management.

Parrett JL, Reaves AB, Self TH, Owens RE. Parrett JL, et al. Among authors: reaves ab. J Clin Pharm Ther. 2018 Apr;43(2):276-279. doi: 10.1111/jcpt.12612. Epub 2017 Sep 12. J Clin Pharm Ther. 2018. PMID: 28901605

5

Activities of Memphis-area hospitals to meet National Patient Safety Goals for warfarin therapy.

Finks SW, Oliphant CS, Manguso AH, Rogers KC, Bridges G, Haidar CE, Lee KR, Lee M, Lobo B, May AM, Reaves A, Swanson JM, Swims M, Vinson J, Yates ME. Finks SW, et al. Am J Health Syst Pharm. 2009 Dec 15;66(24):2179-88. doi: 10.2146/ajhp080475. Am J Health Syst Pharm. 2009. PMID: 19966086

6

Fever as a risk factor for increased response to vitamin K antagonists: a review of the evidence and potential mechanisms.

Self TH, Oliphant CS, Reaves AB, Richardson AM, Sands CW. Self TH, et al. Among authors: reaves ab. Thromb Res. 2015 Jan;135(1):5-8. doi: 10.1016/j.thromres.2014.10.015. Epub 2014 Oct 22. Thromb Res. 2015. PMID: 25456000 Review.

7

Does heart failure exacerbation increase response to warfarin? A critical review of the literature.

Self TH, Reaves AB, Oliphant CS, Sands C. Self TH, et al. Among authors: reaves ab. Curr Med Res Opin. 2006 Nov;22(11):2089-94. doi: 10.1185/030079906X132479. Curr Med Res Opin. 2006. PMID: 17076968 Review.

8

Analysis of gastrointestinal prophylaxis in patients receiving dual antiplatelet therapy with aspirin and clopidogrel.

Morneau KM, Reaves AB, Martin JB, Oliphant CS. Morneau KM, et al. Among authors: reaves ab. J Manag Care Pharm. 2014 Feb;20(2):187-93. doi: 10.18553/jmcp.2014.20.2.187. J Manag Care Pharm. 2014. PMID: 24456320

9

Treatment of warfarin-related intracranial hemorrhage: a comparison of prothrombin complex concentrate and recombinant activated factor VII.

Pinner NA, Hurdle AC, Oliphant C, Reaves A, Lobo B, Sills A. Pinner NA, et al. World Neurosurg. 2010 Dec;74(6):631-5. doi: 10.1016/j.wneu.2010.06.030. World Neurosurg. 2010. PMID: 21492631

10

Supratherapeutic international normalized ratio due to reduced vitamin K intake secondary to prolonged vomiting in a patient on warfarin.

Reaves AB, Clarke CJ, Tillman EM. Reaves AB, et al. Ann Pharmacother. 2013 Jun;47(6):e28. doi: 10.1345/aph.1R688. Ann Pharmacother. 2013. PMID: 23719786

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results